182 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
Statements" and "Use of Non-GAAP Financial Information."
Environmental, Social & Governance (ESG)
As a leading biopharmaceutical company, Bristol
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
STRATEGY & GOVERNANCE Conducted a revised global ESG materiality assessment Expanded ESG operating model to further align with company strategy … Established ESG Council in 2022 as primary governance body for all ESG matters As a leading biopharma company, we understand our responsibility extends well
8-K
EX-99.1
ieka7
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K/A
sfl7 fff2re49tx
31 Oct 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
zhzninjn5g6r
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
ekqs1xjbpbd7ljj
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
0bu8 uct04r6g0ww
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
k83h0wigf4wgv1arglgz
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
385tza4x di
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
1f489tobzshmvume5m
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
EX-99.1
sr9ttq dlx
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
wqiqdlh1cwco3u
20 Apr 22
Additional proxy soliciting materials
4:30pm
PX14A6G
y3lku5ijpq8hesg8h9
5 Apr 22
Letter to shareholders
4:53pm
8-K
EX-99.1
jrgyq8o5m1
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am